The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Damico Jennifer B. since 2020.
This trader's CIK number is 1805617.
At the time of last reporting, Damico Jennifer B. was the SVP & Controller of Pfizer Inc. (stock ticker symbol PFE).
Also see all insider trading activities at Pfizer Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | PFE | 0 | $0 | 2,500 | $64,825 | 31,157 | $965,559 |
| 2024 | PFE | 0 | $0 | 5,154 | $147,713 | 9,752 | $266,619 |
| 2023 | PFE | 0 | $0 | 9,912 | $396,678 | 10,456 | $315,457 |
| 2022 | PFE | 0 | $0 | 8,218 | $429,603 | 21,461 | $569,842 |
| 2021 | PFE | 0 | $0 | 6,661 | $289,417 | 22,363 | $506,550 |
| 2020 | PFE | 0 | $0 | 4,362 | $162,440 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-04 | PFE | Sale | 2,500 | 25.93 | 64,825 |
| 2025-02-27 | PFE | Option Ex | 22,416 | 31.31 | 701,844 |
| 2025-02-22 | PFE | Option Ex | 8,741 | 30.17 | 263,715 |
| 2024-08-13 | PFE | Sale | 5,154 | 28.66 | 147,713 |
| 2024-02-23 | PFE | Option Ex | 9,752 | 27.34 | 266,619 |
| 2023-03-15 | PFE | Sale | 9,912 | 40.02 | 396,678 |
| 2023-02-22 | PFE | Option Ex | 10,456 | 30.17 | 315,457 |
| 2022-06-07 | PFE | Sale | 4,218 | 53.96 | 227,603 |
| 2022-05-16 | PFE | Sale | 4,000 | 50.50 | 202,000 |
| 2022-02-26 | PFE | Option Ex | 9,713 | 25.60 | 248,652 |
| 2022-02-23 | PFE | Option Ex | 11,748 | 27.34 | 321,190 |
| 2021-08-13 | PFE | Sale | 1,661 | 48.30 | 80,217 |
| 2021-07-30 | PFE | Sale | 2,500 | 42.86 | 107,150 |
| 2021-05-05 | PFE | Sale | 2,500 | 40.82 | 102,050 |
| 2021-02-27 | PFE | Option Ex | 9,886 | 22.35 | 220,952 |
| 2021-02-25 | PFE | Option Ex | 12,477 | 22.89 | 285,598 |
| 2020-06-05 | PFE | Sale | 2,181 | 36.13 | 78,799 |
| 2020-04-29 | PFE | Sale | 2,181 | 38.35 | 83,641 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Damico Jennifer B. (SVP & Controller of Pfizer Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.